Arbele

Arbele is a locally grown pharmaceutical biotech focused on immunotherapy of cancers, immune disorders and neurological diseases. The company founding team has a strong combination of business development and pharmaceutical R&D, with an accumulation of >30 year experience in multinational drug companies. Our motto is to excel patient healthcare through innovation and breakthrough. Our mission is to deliver innovative and cost-effective therapeutics to treat diseases of unmet needs. We focus on antibody-based therapeutic platforms, including chimeric antigen receptor (CAR)-T and Bi-specific antibody technology, while leveraging new technology on CRISPR genome editing. Our culture ingredients are integrity and social values

Immune oncology,stem cells,biopharmaceutics,biomarkers,in-vitro diagnostics,and car therapy

Arbele operates in the Biotechnology research industry.

Arbele's revenue is 11m - 100m

Arbele has 11 - 50 employees.